Avanos Medical (AVNS) Change in Account Payables (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Change in Account Payables data on file, last reported at -$2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 67.19% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 151.04% YoY), and the FY2025 full-year result was $600000.0, up 166.67% from the prior year.
• Change in Account Payables declined to -$2.1 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $30.2 million in Q1 2022 to a low of -$14.2 million in Q3 2023.
• A 5-year average of $1.1 million and a median of $1.1 million in 2025 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables surged 587.1% in 2022 and sank 2466.67% in 2023, its largest moves.
• Tracing AVNS's Change in Account Payables over 5 years: stood at $1.3 million in 2022, then increased by 23.08% to $1.6 million in 2023, then sank by 81.25% to $300000.0 in 2024, then surged by 266.67% to $1.1 million in 2025, then tumbled by 290.91% to -$2.1 million in 2026.
• Business Quant data shows AVNS's Change in Account Payables at -$2.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.